The ASEAN's leading Pharmaceutical solutions event
Date
19 October 2022, Wednesday 10:00-18:00 hrs.
20 October 2022, Thursday 10:00-18:00 hrs.
21 October 2022, Friday 10:00-17:00 hrs.
Venue IMPACT, Muang Thong Thani, Thailand
Attendee Statistics According to CPhI Southeast Asia 2019, Number of Attendee is 7,225 from 76 coun
The entire Pharma Industry in one location
Sector Focus:
Pharmaceutical ingredients
Exhibitor profile: APIs, Excipients, Intermediates, Single-use equipment and materials, Supply chain testing services and instruments, Cosmeceuticals, Animal nutrition & animal health, producers, Patented drugs, Natural extract ICSE: for contract manufacturing and services
Pharmaceutical packaging and drug delivery systems
Exhibitor profile: Blister packaging, bottles, packets, Contact packaging services, Equipment to package solid dosage, Semi-solid, and parenteral drugs, Logistics (cold-chain, shipping, tracking), Primary packaging (vials, syringes, transdermal, injector, inhalation systems), Secondary packaging (labelling, printing, boxes, patient dispensing devices), Track and trace / serialization
Pharmaceutical machinery, technology, and equipment
Exhibitor profile: Blister packaging, bottles, packets, Contact packaging services, Equipment to package solid dosage, Semi-solid, and parenteral drugs, Logistics (cold-chain, shipping, tracking), Primary packaging (vials, syringes, transdermal, injector, inhalation systems), Secondary packaging (labelling, printing, boxes, patient dispensing devices), Track and trace / serialization
Outsourcing Solutions
Exhibitor profile: Clinical trial development and management services, Clinical trial drug materials, Contract development Services, Contract Labs, Formulation services, Lab Equipment and Instruments, Pre-clinical testing, Process development services, Regulatory affairs services, Scale-up models, and bench-top systems
Finished dosage formulation
Exhibitor profile: Blisters, sachets and tube packaging, Capsules, Coating, CMO, Dossier specialists, End-product distributors, End-user agents, In/Out-licensing specialists, Oral Solutions, Sachets and Powders blends, Tablets (Immediate, modified release mono layered and bilayer), Natural extract finished products
A dedicated zone showcasing the latest natural extract products, applications, and solutions.
Exhibitor Profiles: Plant Extracts, Animal Extracts, Food & Beverage Raw Materials, TCM Raw Materials, Dietary Supplement, Functional Food Raw Materials, Cosmetics Raw Materials, Nutrition & Health Product
Visitors Profile: Regional and global Pharma manufacturers that are looking for ingredients, Principles that are looking for potential distribution partners, International & regional distributors, Contract manufacturers looking for upscaling activities, Toll manufacturing, Out-licensing specialist, Distribution & Retail, Companies that look for Bio investment: bio-similar production in Indonesia & investors overall
CPhI Southeast Asia 2022 Features
- Health Theatre
- Extract Live Demo
- Natural Innovative Product Packaging showcase
- International conferences and technical seminars
- Business Matching
Southeast Asia’s Industry at glance
Industry Growth
Southeast Asia’s pharmaceutical manufacturing industry will grow by 12.8%
annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.
Opportunities for higher-value industries
ASEAN currently plays a relatively small global role in higher-value industries such as medical technology, biopharmaceuticals, and chemicals. But shifts in global supply chains arising from trade tensions and the COVID-19 pandemic are creating opportunities for ASEAN manufacturers to break into or greatly expand their market share in such sectors.
The rise of middle class population
By 2030, the size of ASEAN’s middle class is expected to reach 334m, accounting for more than half of the population. Middle class consumers tend to be very conscious of health and wellness issues and demand better access to convenient and affordable care. Digital health services are capable of delivering quality healthcare services in a more affordable and accessible manner.
Thailand as a medical hub of ASEAN
Thailand is one of the leading pharmaceutical markets in Southeast Asia. over 2022 and 2023, annual growth in the market should accelerate to 3.5% due to a rising concern among Thais over personal health and wellness, itself partly a side-effect of the Covid-19 pandemic, the aging of Thai society, which is driving an increase in the number of individuals needing treatment for chronic non-communicable diseases, the broad coverage provided by the Universal Health Coverage scheme, and the return of foreign patients to Thai hospitals.
Source: BCG, HKTDC Research, Statista, Krungsri Research
The ASEAN's leading Pharmaceutical solutions event
Date
19 October 2022, Wednesday 10:00-18:00 hrs.
20 October 2022, Thursday 10:00-18:00 hrs.
21 October 2022, Friday 10:00-17:00 hrs.
Venue IMPACT, Muang Thong Thani, Thailand
Attendee Statistics According to CPhI Southeast Asia 2019, Number of Attendee is 7,225 from 76 coun
The entire Pharma Industry in one location
Sector Focus:
Pharmaceutical ingredients
Exhibitor profile: APIs, Excipients, Intermediates, Single-use equipment and materials, Supply chain testing services and instruments, Cosmeceuticals, Animal nutrition & animal health, producers, Patented drugs, Natural extract ICSE: for contract manufacturing and services
Pharmaceutical packaging and drug delivery systems
Exhibitor profile: Blister packaging, bottles, packets, Contact packaging services, Equipment to package solid dosage, Semi-solid, and parenteral drugs, Logistics (cold-chain, shipping, tracking), Primary packaging (vials, syringes, transdermal, injector, inhalation systems), Secondary packaging (labelling, printing, boxes, patient dispensing devices), Track and trace / serialization
Pharmaceutical machinery, technology, and equipment
Exhibitor profile: Blister packaging, bottles, packets, Contact packaging services, Equipment to package solid dosage, Semi-solid, and parenteral drugs, Logistics (cold-chain, shipping, tracking), Primary packaging (vials, syringes, transdermal, injector, inhalation systems), Secondary packaging (labelling, printing, boxes, patient dispensing devices), Track and trace / serialization
Outsourcing Solutions
Exhibitor profile: Clinical trial development and management services, Clinical trial drug materials, Contract development Services, Contract Labs, Formulation services, Lab Equipment and Instruments, Pre-clinical testing, Process development services, Regulatory affairs services, Scale-up models, and bench-top systems
Finished dosage formulation
Exhibitor profile: Blisters, sachets and tube packaging, Capsules, Coating, CMO, Dossier specialists, End-product distributors, End-user agents, In/Out-licensing specialists, Oral Solutions, Sachets and Powders blends, Tablets (Immediate, modified release mono layered and bilayer), Natural extract finished products
A dedicated zone showcasing the latest natural extract products, applications, and solutions.
Exhibitor Profiles: Plant Extracts, Animal Extracts, Food & Beverage Raw Materials, TCM Raw Materials, Dietary Supplement, Functional Food Raw Materials, Cosmetics Raw Materials, Nutrition & Health Product
Visitors Profile: Regional and global Pharma manufacturers that are looking for ingredients, Principles that are looking for potential distribution partners, International & regional distributors, Contract manufacturers looking for upscaling activities, Toll manufacturing, Out-licensing specialist, Distribution & Retail, Companies that look for Bio investment: bio-similar production in Indonesia & investors overall
CPhI Southeast Asia 2022 Features
- Health Theatre
- Extract Live Demo
- Natural Innovative Product Packaging showcase
- International conferences and technical seminars
- Business Matching
Southeast Asia’s Industry at glance
Industry Growth
Southeast Asia’s pharmaceutical manufacturing industry will grow by 12.8%
annually with a total addressable market cap of $148.3 billion over 2021-2027 driven by increasing prevalence of chronic ailments, growing geriatric population, high investment in research and development, and increasing per capita healthcare expenditure amid the COVID-19 pandemic.
Opportunities for higher-value industries
ASEAN currently plays a relatively small global role in higher-value industries such as medical technology, biopharmaceuticals, and chemicals. But shifts in global supply chains arising from trade tensions and the COVID-19 pandemic are creating opportunities for ASEAN manufacturers to break into or greatly expand their market share in such sectors.
The rise of middle class population
By 2030, the size of ASEAN’s middle class is expected to reach 334m, accounting for more than half of the population. Middle class consumers tend to be very conscious of health and wellness issues and demand better access to convenient and affordable care. Digital health services are capable of delivering quality healthcare services in a more affordable and accessible manner.
Thailand as a medical hub of ASEAN
Thailand is one of the leading pharmaceutical markets in Southeast Asia. over 2022 and 2023, annual growth in the market should accelerate to 3.5% due to a rising concern among Thais over personal health and wellness, itself partly a side-effect of the Covid-19 pandemic, the aging of Thai society, which is driving an increase in the number of individuals needing treatment for chronic non-communicable diseases, the broad coverage provided by the Universal Health Coverage scheme, and the return of foreign patients to Thai hospitals.
Source: BCG, HKTDC Research, Statista, Krungsri Research
